CLOROTEKAL Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Clorotekal, and what generic alternatives are available?

Clorotekal is a drug marketed by B Braun Medical Inc and is included in one NDA. There are two patents protecting this drug.

This drug has thirty-one patent family members in twenty-seven countries.

The generic ingredient in CLOROTEKAL is chloroprocaine hydrochloride. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Clorotekal

A generic version of CLOROTEKAL was approved as chloroprocaine hydrochloride by HIKMA on September 9^th, 1998.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CLOROTEKAL?
What are the global sales for CLOROTEKAL?
What is Average Wholesale Price for CLOROTEKAL?

Summary for CLOROTEKAL

International Patents:	31
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	58
Clinical Trials:	2
Patent Applications:	752
Drug Prices:	Drug price information for CLOROTEKAL
What excipients (inactive ingredients) are in CLOROTEKAL?	CLOROTEKAL excipients list
DailyMed Link:	CLOROTEKAL at DailyMed

Drug patent expirations by year for CLOROTEKAL

Recent Clinical Trials for CLOROTEKAL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Oregon Health and Science University	Phase 4
B. Braun Medical Inc.	Phase 4
University of Alabama at Birmingham	Phase 2

See all CLOROTEKAL clinical trials

Pharmacology for CLOROTEKAL

Drug Class	Ester Local Anesthetic
Physiological Effect	Local Anesthesia

US Patents and Regulatory Information for CLOROTEKAL

CLOROTEKAL is protected by two US patents.

Patents protecting CLOROTEKAL

Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD FOR INDUCING A REGIONAL ANAESTHESIA VIA INTRATHECAL ADMINISTRATION OF A PATENTED PRESERVATIVE FREE SOLUTION FOR INJECTION (WITH A SPECIFIC COMPOSITION, PH, OSMOLALITY AND DENSITY) CONTAINING 9-11 MG/ML CHLOROPROCAINE HCL

Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun Medical Inc	CLOROTEKAL	chloroprocaine hydrochloride	SOLUTION;INTRATHECAL	208791-001	Sep 26, 2017		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
B Braun Medical Inc	CLOROTEKAL	chloroprocaine hydrochloride	SOLUTION;INTRATHECAL	208791-001	Sep 26, 2017		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for CLOROTEKAL

See the table below for patents covering CLOROTEKAL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	2009507807		⤷ Sign Up
Philippines	12015501313	CHLOROPROCAINE-BASED PHARMACEUTICAL COMPOSITION FOR REPEATED INTRATHECAL ADMINISTRATION	⤷ Sign Up
New Zealand	709631	Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration	⤷ Sign Up
Argentina	099443	COMPOSICIÓN FARMACÉUTICA A BASE DE CLOROPROCAÍNA PARA LA ADMINISTRACIÓN INTRATECAL REPETIDA	⤷ Sign Up
Australia	2013356855	Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration	⤷ Sign Up
Cyprus	1114743		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration